Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection

ClinicalTrials.gov ID: NCT07804446

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07804446. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Does Injection Site (Anteromedial vs Anterolateral) Affect Pain Relief After Intra-Articular Corticosteroid Injection in Moderate-to-Severe Medial Knee Osteoarthritis?

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to find out if there is a difference in pain experienced in patients with knee arthritis of the inside of their knee if they get a steroid injection on the inside or outside of their knee. Participants will: 1. Be randomly divided into getting their steroid injection on the inside or outside of their knee. 2. Answer a pain survey before their injection as well as over the phone 2 weeks, 6 weeks, and 12 weeks after their injection.

Study identification

NCT ID: NCT07804446
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Chicago; Other
Enrollment: 140 participants

Conditions and interventions

Conditions

Interventions

Anteromedial Injection Procedure
Anterolateral Injection Procedure

Procedure

Eligibility (public fields only)

Age range: 40 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2026 (Actual)
Primary completion: Apr 1, 2027 (Estimated)
Completion: May 1, 2027 (Estimated)
Last update posted: Sep 4, 2026

2026 – 2027

United States locations

U.S. sites: 5
U.S. states: 1
U.S. cities: 5

Facility	City	State	ZIP	Site status
Bolingbrook Clinic	Bolingbrook	Illinois	60440	Recruiting
Hyde Park Clinic	Chicago	Illinois	60637	Recruiting
La Grange Clinic	La Grange	Illinois	60525	Recruiting
Orland Park Clinic	Orland Park	Illinois	60462	Recruiting
Woodridge Clinic	Woodridge	Illinois	60517	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07804446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 4, 2026 · Synced Nov 15, 2026